Baby Formula Makers Abbott and Reckitt See Stocks Slide

Baby Formula Makers Abbott and Reckitt See Stocks Slide as Judge Allows Retrial
Key Takeaways Infant formula makers Abbott and Reckitt saw their stocks decline Friday after a judge ruled plaintiffs could pursue a new trial against the companies.A jury in October found the companies not liable in a case alleging their infant formula products caused necrotizing enterocolitis,
Abbott, Reckitt face new trial over premature infant formula
A Missouri judge has ordered Abbott Laboratories and Reckitt Benckiser unit Mead Johnson to face a new trial over allegations that they failed to warn a mother about the risks of their specialized baby formulas for premature infants,
Abbott and Reckitt Fall on News of New Infant Formula Trial
Abbott Laboratories and Reckitt Benckiser Group Plc shares fell as a judge ordered a new trial after rejecting a verdict that had cleared the companies of liability over claims they hid potential risks of their premature-infant formulas.
That baby formula trial Abbott and Reckitt won isn't over just yet
Back in October, a jury found North Chicago-based Abbott and Reckitt’s formula subsidiary Mead Johnson not responsible for a baby developing necrotizing enterocolitis, or NEC, from their cow-milk-based formulas. NEC is a serious, and sometimes deadly, gastrointestinal disease that primarily afflicts premature infants.
‘A Manifest Injustice': Judge Who Sanctioned Abbott’s Counsel Grants New Infant Formula Trial
Missouri 22nd Judicial Circuit Court Judge Michael Noble granted the plaintiff's motion for a new trial on Thursday, citing the “widespread misconduct” of defendants Abbott Laboratories Inc. and Mead Johnson.
Abbott Labs, Reckitt Benckiser Shares Fall After New Ruling on Infant Formula Case
Shares of Abbott Laboratories and Reckitt Benckiser fell Friday after a judge ruled a new trial could be heard involving a case on their infant formula products that had already seen a ruling in their favor.
In a setback for Abbott Laboratories, judge allows new trial in case over formula for premature infants
The decision to allow a new trial could have  implications for both the companies and families with babies born prematurely.
Abbott stock falls following retrial order in infant formula case
The ruling overturned a previous verdict related to an infant formula case and has implications for both Abbott and Reckitt, with the latter’s shares also falling by 4.5%. The legal battle revolves around the Whitfield case, which pertains to the alleged link between infant formula and necrotizing enterocolitis (NEC) in premature infants.
Reckitt says US court grants new trial in premature-infant formula case
Reckitt said on Friday a U.S. circuit court has ruled that a new trial could be sought by plaintiffs in a case that had accused the London-listed firm and Abbott of failing to warn of the risks of premature baby formulas.
Reckitt Shares Drop on Infant Formula Retrial in U.S.
Reckitt Benckiser shares fell after a U.S. judge ordered a retrial of an infant-formula lawsuit that had found in the consumer-goods company's favor. In afternoon trading Friday, London-listed shares were down 2.
He Fought Claims of Harm From Infant Formula. Now He Regulates It.
Kyle Diamantas, a former corporate lawyer, is the new director for the F.D.A. food division, which oversees infant formula.
Why Abbott Laboratories (ABT) Went Down On Friday?
We recently published a list of Friday’s 10 Worst Performing Stocks. In this article, we are going to take a look at where ...
S&P 500 Gains and Losses Today: Index Bounces Off Lows as Government Shutdown Concerns Ease
The S&P 500 jumped 2.1% on Friday, March 14, wrapping up a volatile week as government shutdown concerns eased.
Citi sees overturned verdict in state case as incrementally negative for Abbott
Citi notes that Investing.com reported on Friday that the judge in the Whitfield infant formula case has overturned the October 31 verdict, ...